Brindle & Bay Financial Advisors »

Halozyme Therapeutics shares owned by Brindle & Bay Financial Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Brindle & Bay Financial Advisors from 13F filings

Historical chart of Brindle & Bay Financial Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Brindle & Bay Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Brindle & Bay Financial Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $223k 2.9k 78.26

More positions owned by Brindle & Bay Financial Advisors

Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Spdr Series Trust St Bloo High Etf (JNK)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Series Trust St Str Conv Etf (CWB)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Pfd And Incm Sec (PFF)
Vanguard Index Fds Mcap Vl Idxvip (VOE)

View all positions for Brindle & Bay Financial Advisors

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Robeco Investment Management
Bank of America Corporation
Morgan Stanley
Geode Capital Management
William Blair Investment Management
Snyder Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co
Thomas Stevens, CFA"
Royal London Asset Management

View all funds holding Halozyme Therapeutics